Related Experiment Video
Updated: Jun 12, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
The association between neopterin and acetaminophen-induced nephrotoxicity
Erdinc Cakir1, Ozgur E Akgul, Ibrahim Aydin
1Department of Medical Biochemistry, Gulhane Military Medical Academy, Etlik, Ankara, Turkey.
Neopterin levels in serum and kidneys can identify acetaminophen-induced kidney injury. Elevated neopterin indicates acute histological kidney damage from acetaminophen overdose.
Area of Science:
- Toxicology
- Biochemistry
- Nephrology
Background:
- Acetaminophen (APAP) overdose causes acute kidney necrosis in mammals.
- Neopterin levels are indicators of disease severity.
- The study investigates neopterin as a biomarker for APAP-induced nephrotoxicity.
Purpose of the Study:
- To evaluate neopterin as a biomarker for acetaminophen-induced nephrotoxicity.
- To assess the correlation between neopterin levels and kidney injury.
Main Methods:
- Wistar rats were administered single doses of APAP (1 or 2 g/kg).
- Kidney tissues and blood were analyzed for biochemical and histopathological changes.
- Serum and kidney neopterin levels were measured and compared to controls.
Main Results:
- APAP treatment led to tubular necrosis and increased serum creatinine.
- Both serum and kidney neopterin levels were significantly elevated in APAP-treated rats.
- A dose-dependent increase in kidney neopterin and tubular injury was observed.
Conclusions:
- Neopterin is a potential biomarker for assessing the risk of APAP-induced nephrotoxicity.
- Elevated neopterin levels correlate with acute histological kidney injury from APAP overdose.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Toxicity: Dose-Dependent Reactions
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction